Abstract Interferon-gamma (IFNc) has previously been associated with immuno-mediated inflammation in dietinduced obesity and type 1 diabetes. This study sought to define the role of IFNc-induced adipose tissue inflammation in endothelial dysfunction in type 2 diabetes. We examined mesenteric adipose tissue (MAT) inflammation, and endothelial function of small mesenteric artery (SMA) 
Introduction
The onset of an obesity and type 2 diabetes pandemic has gained wide recognition [21] . Increased adiposity, especially abdominal adiposity, is associated with an increase in cardiovascular risk factors [39] , although the mechanisms underlying these associations are not well understood. Accumulating evidence suggests that adipose tissue plays a critical role in the regulation of vascular function by releasing relaxing and contracting factors, pro-inflammatory cytokines/chemokines, hormones, and superoxide [7, 12, 14, 15, 25] . The pathogenic role of adipose tissue in type 2 diabetes is supported by clinical evidence that weight loss leads to improvement in glycemic control [11] . Thus, characterization of the biological and pathological functions of various adipose-derived factors will expand Electronic supplementary material The online version of this article (doi:10.1007/s00395-011-0212-x) contains supplementary material, which is available to authorized users. our understanding of the communication between the perivascular adipose and blood vessels and how adipose tissue affects vascular function through endocrine/paracrine actions in obese and type 2 diabetic patients [7, 52] .
Obesity and type 2 diabetes are characterized by lowgrade systemic inflammation, which is caused, at least in part, by inflamed adipose tissue [52] . Adipocytes are intrinsically capable of producing various pro-inflammatory cytokines/chemokines. Furthermore, adipose tissue inflammation may also be due to macrophage that has been shown to infiltrate adipose tissue [18] . Increased macrophage infiltration into adipose tissue is associated with insulin resistance and endothelial dysfunction in obese subjects [1, 17] . T lymphocyte infiltration in visceral adipose tissue occurs prior to the infiltration of macrophage and the development of insulin resistance in high-fat diet treated mice [22] . Together, this suggests that T lymphocyte infiltration may be a primary event that orchestrates the inflammation of adipose tissue [4] . Both T cells and natural killer (NK) cells express interferon-gamma (IFNc) on activation [6, 30] . Obese IFNc-deficient animals showed significantly reduced densities of inflammatory cells in adipose tissue, and better glucose tolerance than control animals when fed with the same diet [37] . Despite the established role of IFNc in mediating the immune response in type 1 diabetes and diet-induced obesity [6, 37] , the role of IFNc in inducing adipose tissue inflammation in type 2 diabetes and the mechanisms of the crosstalk between IFNc-induced adipose tissue inflammation/oxidative stress and vascular dysfunction have not been studied. Thus, the objective of this study is to test the hypothesis that IFNcinduced adipose tissue inflammation/oxidative stress is linked to endothelial dysfunction in type 2 diabetes. We examined the role of IFNc in adipose tissue inflammation/ oxidative stress and its vascular pro-oxidant mechanisms putatively involved in the increased oxidative stress/ reduced generation of NO in type 2 diabetic mice.
Methods

Animal models and treatment
The procedures followed were in accordance with approved guidelines set by the Animal Care Committee at the University of Missouri. Heterozygote control mice (m Lepr db ) (Background Strain: C57BLKS/J), and homozygote type 2 diabetic mice (Lepr db ) (Background Strain: C57BLKS/J) were purchased from Jackson Laboratory (Bar Harbor, Maine) and maintained on a normal rodent chow diet. 12-16 week-old, male, 20-35 g m Lepr db , and 40-60 g Lepr db mice were used in this study. m Lepr db was treated with murine recombinant IFNc (R&D, Cat# 485-MI-100/ CF, 330 lg/kg/day, i.p. injection, 5 days) [20] . Lepr db was treated with neutralizing antibody to IFNc (anti-IFNc, R&D, Cat#AF-485-NA, 250 lg/kg/day, i.p. injection, 4 days) or neutralizing antibody to MCP-1 (anti-MCP-1, Biovision, Cat#5225-100, 200 lg/kg/day, i.p. injection, 3 days) [35] . mRNA expression by real time polymerase chain reaction Total RNA was extracted from mesenteric adipose tissue (MAT) or small mesenteric artery (SMA) samples using RNeasy Lipid Tissue Mini Kit (Qiagen) or RNeasy Plus Micro Kit (Qiagen), respectively. cDNA was amplified with the use of qRT-PCR Kit with SYBR Ò Green (Invitrogen). The primer sets were designed by Primer3 software [37, 41, 50] . Quantification was performed using the 2 -DDCT method (DDCT = C T. target -C T. b-actin ) [34] . Results were presented as fold change of transcripts for target normalized to internal control (b-actin), compared with m Lepr db (defined as 1.0 fold).
Protein expression by western blot analyses
Protein expression in MAT or SMA samples was detected using IFNc primary antibody (Millipore, Cat#MAB1152, 1:500), MCP-1 primary antibody (Abcam, Cat#ab8101, 1:100), or nitrotyrosine primary antibody (Abcam, Cat#ab7048, 1:500). Signals were visualized by enhanced chemiluminescence (ECL, Santa Cruz), scanned densitometrically using Fuji LAS3000 and quantified with Multigauge software (Fujifilm).
Immunohistochemistry
MAT was fixed in 10% Z-fix, and embedded in paraffin. 5 lm sections were stained for rabbit anti-mouse CD3 (Abcam, Cat#ab16669, 1:200), rat anti-mouse F4/80 (Abcam, Cat#ab6640, 1:200), or rat anti-mouse Mac-3 (BD Bioscience, Cat#550292, 1:800), then incubated with appropriate biotinylated secondary antibodies followed by incubation with avidin-biotin complex (Vector). The reaction was visualized with 3-amino-9 ethyl carbazole (DAKO). Sections were counterstained with Gill's hematoxylin solution (Sigma) [44] .
Quantification of immunohistochemical staining data
The microscope (Leica CME) was set to 109 magnification and positive staining of macrophages accumulated in the adventitia of SMA was observed in consecutive fields of the entire section. The percentage of macrophage-positive SMA over the total number of SMA being counted for each sample was calculated and statistically analyzed. The passive tension-internal circumference was determined by stretching to achieve an internal circumference equivalent to 60-70% of that of the blood vessel under a transmural pressure of 100 mmHg. A cumulative doseresponse curve was obtained by adding acetylcholine (ACh, 1 nmol/L-10 lmol/L) and sodium nitroprusside (SNP, 1 nmol/L-10 lmol/L). Relaxation at each concentration was measured and expressed as the percentage of force generated in response to 1 lmol/L phenylephrine (PE) [32, 40] . NO availability and ROS production were evaluated by ACh concentration-response curve repeated after incubation with the NO synthase inhibitor N-Nitro-Larginine methyl ester (L-NAME, 100 lmol/L, 20 min) and the anti-oxidant and superoxide dismutase mimetic TEM-POL (3 mmol/L, 60 min), respectively.
Measurement of superoxide using electron paramagnetic resonance spectroscopy Measurement of superoxide using electron paramagnetic resonance spectroscopy (EPR) was performed as previously described [13, 49] . In brief, a 10% MAT or SMA tissue homogenate containing 2 mmol/L CPH (1-hydrox-3-carboxypyrrolidine) was prepared in a 50 mmol/L phosphate buffer with 0.01 mmol/L EDTA and were incubated for 30 min at 37°C and frozen quickly in liquid nitrogen for measurement.
Data analysis
All data were presented as mean ± SEM except as specifically stated. Statistical comparisons were performed with 2-way ANOVA for vasomotor responses under various treatments, and with one-way ANOVA for other data.
Intergroup differences were tested with Fisher's least significant difference test. Significance was accepted at P \ 0.05. Expanded materials and methods are provided in the Online Supplement. (Fig. 1) . In addition to IFNc and MCP-1, we also examined the mRNA expression of other adipose-derived factors in MAT of control and diabetic mice. The results indicate there were no differences in MAT mRNA expression of adiponectin, interleukin-10 (IL-10), RANTES, IL-6, and monokine induced by gamma-interferon (MIG) between control and diabetic mice (Supplemental Fig. 2) .
Results
Role of
We examined the infiltration of CD3 positive T lymphocytes, F4/80 and Mac-3 positive macrophages in MAT of m Lepr db , Lepr db , Lepr db treated with anti-IFNc or anti-MCP-1, and m Lepr db treated with IFNc using immunohistochemical staining. Multiple macrophages and lymphocytes fused around dead adipocytes to form crown-like structures (CLS), which were prevalent in MAT of Lepr db (Fig. 2a) . mRNA expression of CD3, CD4, CD8, and CD68 was increased in MAT of Lepr db versus control mice. Anti-IFNc reduced mRNA expression of T lymphocyte and macrophage markers, while IFNc increased the mRNA levels of CD3, CD4, CD8, and CD68 in m Lepr db mice. Anti-MCP-1 reduced macrophage infiltration, but did not significantly affect MAT T lymphocyte infiltration in Lepr db mice (Fig. 2b-e) . The expression of macrophage marker CD68 in periaortic adipose tissue (PAT) and interscapular brown adipose tissue (BAT) was relatively lower compared with that in MAT in all groups, and there were no statistical differences in PAT and BAT CD68 expression between control and diabetic mice. However, CD68 expression in epididymal white adipose tissue (EWAT) and inguinal subcutaneous adipose tissue (SCAT) was significantly higher in diabetic mice and IFNc-treated control mice, but anti-IFNc treatment to diabetic mice only minimally reduced the CD68 expression in EWAT and SCAT (Fig. 2f) .
Role of IFNc in endothelial dysfunction in type 2 diabetic mice
Endothelium-dependent vasorelaxation of SMA to ACh was impaired in Lepr db versus m Lepr db (Fig. 3) . AntiIFNc and anti-MCP-1 improved endothelial function of Lepr db , but IFNc impaired ACh-induced vasorelaxation of control mice (Fig. 3a, c) . The endothelium-independent vasorelaxation to sodium nitroprusside (SNP) and vasoconstriction to PE were identical among all groups (Fig. 3b, d and Supplemental Fig. 3) .
TEMPOL incubation restored the endothelial function of Lepr db back to the level of control mice (Fig. 4a) . L-NAME incubation abolished the difference in endothelium-dependent vasorelaxation between control and diabetic mice (Fig. 4b) .
The link between adipose tissue inflammation/oxidative stress and endothelial dysfunction in type 2 diabetic mice
The accumulation of Mac-3 positive macrophages in the adventitia of SMA vascular wall was higher in diabetic mice versus control mice. Anti-IFNc reduced macrophage accumulation in SMA of Lepr db mice, but IFNc showed opposite effects in control mice (Fig. 5a, b) . Moreover, the mRNA expression of MCP-1 was higher in the SMA of diabetic mice. Anti-IFNc reduced mRNA expression of MCP-1 in SMA of Lepr db mice, but IFNc treatment to control mice increased SMA MCP-1 expression (Fig. 5c) . However, the mRNA expression of VCAM-1, ICAM-1 and E-selectin in SMA was not different between control and diabetic mice (Supplements Fig. 4 ). Serum level of MCP-1 was comparable in diabetic and control mice (Fig. 5d) . Serum level of inflammatory cytokine tumor necrosis factor-alpha (TNFa) was elevated in diabetic mice and control mice treated with IFNc (Fig. 5e) .
Superoxide production was elevated in both MAT and SMA of diabetic mice. Anti-IFNc and anti-MCP-1 ameliorated both MAT and SMA superoxide production, while IFNc increased MAT/SMA superoxide levels (Fig. 6a, b) . Moreover, nitrotyrosine protein expression was higher in SMA of diabetic mice. Both anti-IFNc and anti-MCP-1 decreased nitrotyrosine levels in SMA of Lepr db , but IFNc treatment to m Lepr db increased SMA nitrotyrosine protein expression (Fig. 6c) .
Discussion
Endothelial dysfunction is an important factor in the pathogenesis of cardiovascular disorders and has gained increasing attention in the study of obesity and diabetesassociated vascular complications [3, 16, 31] . Central adiposity, particularly a greater amount of intraabdominal or visceral fat, contributes to chronic subclinical inflammation, which is linked to endothelial dysfunction and atherosclerosis [43] . The study of the T lymphocyte/macrophage infiltration and adipose tissue inflammation in type 2 diabetic mice Obesity is associated with inflammatory cell accumulation in the adipose tissue [46] . Diet-induced increases in adiposity promote macrophage infiltration into white adipose tissue and the extent of macrophage accumulation correlates with the degree of adiposity [8] . In addition to macrophages, T lymphocytes have recently been identified as a key player in adipose tissue inflammation by orchestrating the evolution of the inflammatory cascade [29] . In patients with type 2 diabetes, lymphocyte content in adipose tissue biopsies is significantly correlated with waist circumference, a marker of central adiposity, and insulin resistance [22] . Our results suggest that the increased IFNc expression in MAT in Lepr db was accompanied by enhanced T lymphocyte/macrophage infiltration. Immunohistochemical staining generally showed T lymphocytes in clusters with macrophages, which formed CLS around adipocytes. AntiIFNc reduced MAT IFNc and MCP-1 expression, as well as the T lymphocyte and macrophage infiltration. Anti-MCP-1 reduced macrophage infiltration, but did not significantly affect IFNc expression and T lymphocyte infiltration (Figs. 1, 2) . Thus, although T lymphocytes are quantitatively less prominent than macrophages [37] , T cells may decisively affect the infiltration of macrophages, and the expression of macrophage-derived chemokines, in the visceral adipose tissue of type 2 diabetic mice.
Adipose tissue inflammation and endothelial dysfunction in type 2 diabetic mice Growing evidence suggests a link between adipose tissue inflammation and endothelial dysfunction [1, 26] . The production of inflammatory cytokines and hormones by adipose tissue is of particular interest, since their local secretion by peri-vascular adipose deposits may provide a novel mechanistic link between obesity and diabetesassociated vascular complications [5, 7, 19] . The secretory products from human adipocytes stimulated pro-inflammatory cytokine secretion by human umbilical venous endothelial cells (HUVECs), suggesting that endothelial cell secretion was significantly tilted towards a proinflammatory pattern by adipocyte-derived factors [9, 38] . Moreover, macrophages stimulated with IFNc activate nuclear factor-kappa B (NF-Kb) and induce MCP-1 gene expression in HUVECs, which posits to a possible interaction between adipose inflammatory cells and vascular cells [36] . Mesenteric vasculature regulates total blood flow to the gut and mediates transport of nutrients in the circulation [24] . The mesenteric bed is surrounded by a variable volume of peri-vascular mesenteric adipose tissue, which plays an important role in sustaining an inflammation cascade in obesity and type 2 diabetes [14] . Changes in the fat may have consequences for the regulation of mesenteric artery tone and mesenteric endothelial function [12] . Thus, SMA is an ideal model to study the possible local effects of MAT inflammation on vascular function. Oxidative stress and inflammation are known to be the key mechanisms in the pathogenesis of vascular dysfunction in atherosclerosis, myocardial ischemia/reperfusion, and diabetes [2, 42, 45, 48] . Many adipose-derived cytokines, such as IL-6, TNFa, and MCP-1 profoundly stimulate ROS production and reduce NO bioavailability [23, 33, 52, 53] . Our results show that ACh-induced vasorelaxation was impaired in SMA of Lepr db . This impairment was completely restored by SOD mimetic, TEMPOL, incubation (Fig. 4a) . L-NAME incubation abolished the difference in endothelium-dependent vasorelaxation between control and diabetic mice (Fig. 4b) (Fig. 6 ). The profound MAT oxidative stress and macrophage accumulation in the vascular wall of SMA may serve as link between MAT inflammation and SMA endothelial dysfunction. In Lepr db mice, the superoxide production is elevated in both MAT and SMA. By normalizing the superoxide level of MAT/SMA to the protein content, the superoxide production is quantitatively more prominent in MAT than in SMA (Fig. 6a, b) . Anti-IFNc reduced MAT superoxide production in Lepr db , but IFNc increased MAT oxidative stress in m Lepr db mice (Fig. 6a) . Moreover, macrophage accumulation in the adventitia of mesenteric vessels was significantly higher in Lepr db and m Lepr db treated with IFNc. Lepr db treated with anti-IFNc showed reduced macrophage accumulation in SMA. mRNA expression of MCP-1 was also elevated in the SMA of diabetic mice and anti-IFNc treatment attenuated the MCP-1 expression in SMA (Fig. 5c) . Importantly, compared with the remarkable impairment of SMA endothelial function following IFNc systemic in vivo administration, in vitro incubation of the adipose-free vessel with a pathological concentration of murine recombinant IFNc (1.6 or 16 ng/ml for 1 h, or 16 ng/ml for 4 h) did not significantly affect ACh-dependent SMA vasorelaxation (Supplemental Fig. 5 ). This suggests that the role of IFNc in the impairment of vascular function occurs indirectly following IFNc-induced adipose tissue inflammation.
Separating the local versus systemic effects of adipose tissue on the regulation of vascular function is also important. Although adipose tissue is considered as a potential systemic source of inflammation, only a limited number of adipose-derived cytokines are released into the circulation in sufficient amounts to account for obesityassociated increased systemic levels [28] . The trivial contribution of adipose-derived MCP-1 [10] , TNFa [27] , and PAI-1 [47] to the circulating concentrations has been demonstrated by measuring the arteriovenous difference over the inferior epigastric vein [28] . In fact, although MCP-1 expression was increased in Lepr db MAT, the serum level of MCP-1 was not statistically different between control and diabetic mice (Fig. 5d) . The serum level of TNFa was higher in diabetic mice and IFNctreated control mice (Fig. 5e) . However, as a chronic disease model, the circulating concentration of TNFa in the pg/ml range is unlikely to cause endothelial dysfunction in type 2 diabetic mice [51] . Therefore, mesenteric adipose tissue exhibiting a pro-inflammatory phenotype may primarily exert local effects by promoting inflammatory cell accumulation and the release of inflammatory cytokines, thereby enhancing vascular inflammation/oxidative stress and attenuating endothelial function.
In conclusion, our study suggests that IFNc-induced adipose tissue inflammation and oxidative stress is linked to endothelial dysfunction in type 2 diabetes. These findings help define the linkage between adipose tissue inflammation and vascular dysfunction and highlight the therapeutic potential of anti-IFNc for alleviating diabetesrelated vascular complications, which may result in better remediation strategies in the longer term.
